Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells?
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-19
DOI
10.3389/fonc.2021.703878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
- (2021) Asieh Emami Nejad et al. Cancer Cell International
- Signaling Pathway Mediating Myeloma Cell Growth and Survival
- (2021) Teru Hideshima et al. Cancers
- Ways into Understanding HIF Inhibition
- (2021) Tina Schönberger et al. Cancers
- Role of hypoxia‑inducible factor‑2α in lung cancer (Review)
- (2021) Wen-Jun Wang et al. ONCOLOGY REPORTS
- Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
- (2020) Yolla Haibe et al. Frontiers in Oncology
- Independence of HIF1a and androgen signaling pathways in prostate cancer
- (2020) Maxine G. B. Tran et al. BMC CANCER
- The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome
- (2020) Wai Hoong Chang et al. CANCER LETTERS
- “Take My Bone Away?” Hypoxia and bone: A narrative review
- (2020) Scott S. Hannah et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Genome instability in multiple myeloma
- (2020) Carl Jannes Neuse et al. LEUKEMIA
- Influence of metformin on HIF-1 pathway in multiple myeloma
- (2020) Kinga A. Kocemba-Pilarczyk et al. Pharmacological Reports
- The control of acidity in tumor cells: a biophysical model
- (2020) Nicola Piasentin et al. Scientific Reports
- Pharmacologic Targeting of Hypoxia-Inducible Factors
- (2019) Gregg L. Semenza Annual Review of Pharmacology and Toxicology
- EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
- (2019) Ruyang Zhang et al. Epigenetics
- HIF Inhibitors: Status of Current Clinical Development
- (2019) Jaleh Fallah et al. Current Oncology Reports
- The impact of the bone marrow microenvironment on multiple myeloma (Review)
- (2019) Jianhao Hou et al. ONCOLOGY REPORTS
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer
- (2018) Jiaqi Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
- (2018) Srishti Singh et al. MOLECULES
- Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo
- (2018) Shen-Han Lee et al. BRITISH JOURNAL OF CANCER
- The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets
- (2018) Normann Steiner et al. PLoS One
- Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
- (2018) Claudiu T. Supuran EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3
- (2018) Liang Lin et al. LEUKEMIA
- HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies
- (2017) I. Gladek et al. GENES CHROMOSOMES & CANCER
- SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43
- (2017) Jie Jin et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Roles of pH and the Na + /H + exchanger NHE1 in cancer: From cell biology and animal models to an emerging translational perspective?
- (2017) Christian Stock et al. SEMINARS IN CANCER BIOLOGY
- Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review
- (2017) Bum Jun Kim et al. Oncotarget
- Hypoxia and Bone Metastatic Disease
- (2017) Rachelle W. Johnson et al. Current Osteoporosis Reports
- Restoration of the prolyl-hydroxylase domain protein-3 oxygen-sensing mechanism is responsible for regulation of HIF2α expression and induction of sensitivity of myeloma cells to hypoxia-mediated apoptosis
- (2017) Gilberto Gastelum et al. PLoS One
- Prolyl Hydroxylase 3 Attenuates MCL-1–Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells
- (2016) Praveenkumar Radhakrishnan et al. CANCER RESEARCH
- Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
- (2016) G P Soriano et al. LEUKEMIA
- A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity
- (2016) V. S. Mysore et al. MOLECULAR CANCER RESEARCH
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth
- (2016) Michael S. Nakazawa et al. Nature Communications
- A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
- (2016) Ryota Amachi et al. Oncotarget
- The role of SH3GL3 in myeloma cell migration/invasion, stemness and chemo-resistance
- (2016) Ruoying Chen et al. Oncotarget
- Hypoxia and Hypoxia-Inducible Factors in Leukemias
- (2016) Margaux Deynoux et al. Frontiers in Oncology
- Modulation of Cell Metabolic Pathways and Oxidative Stress Signaling Contribute to Acquired Melphalan Resistance in Multiple Myeloma Cells
- (2015) Kamila Anna Zub et al. PLoS One
- Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions
- (2015) Oihana Iriondo et al. Oncotarget
- The osteoblastic niche in the context of multiple myeloma
- (2014) Denise Toscani et al. Annals of the New York Academy of Sciences
- Membrane Carbonic Anhydrase IX Expression and Relapse Risk in Resected Stage I–II Non–Small-Cell Lung Cancer
- (2014) David J. Stewart et al. Journal of Thoracic Oncology
- Direct measurement of local oxygen concentration in the bone marrow of live animals
- (2014) Joel A. Spencer et al. NATURE
- The chemistry, physiology and pathology of pH in cancer
- (2014) P. Swietach et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
- (2014) B Muz et al. Blood Cancer Journal
- Hypoxia and Metabolic Properties of Hematopoietic Stem Cells
- (2013) Cheng Cheng Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
- (2013) P Storti et al. LEUKEMIA
- Mammalian Target of Rapamycin Inhibitors Induce Tumor Cell ApoptosisIn VivoPrimarily by Inhibiting VEGF Expression and Angiogenesis
- (2013) Patrick Frost et al. Journal of Oncology
- Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
- (2012) A. K. Azab et al. BLOOD
- Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
- (2012) J. Hu et al. Disease Models & Mechanisms
- Bone Marrow Microenvironment in Multiple Myeloma Progression
- (2012) S. Manier et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Suppression of Glioma Progression by Egln3
- (2012) Vicki A. Sciorra et al. PLoS One
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Adaptation to Survival in Germinal Center Is the Initial Step in Onset of Indolent Stage of Multiple Myeloma
- (2011) Ariosto S. Silva et al. MOLECULAR PHARMACEUTICS
- Oxygen Sensing, Homeostasis, and Disease
- (2011) Gregg L. Semenza NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenesis of Monoclonal Gammopathy of Undetermined Significance and Progression to Multiple Myeloma
- (2011) Adriana Zingone et al. SEMINARS IN HEMATOLOGY
- Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug
- (2010) J. Hu et al. BLOOD
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
- (2009) A.-T. Henze et al. CANCER RESEARCH
- The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
- (2009) Eleftheria Hatzimichael et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The angiogenic switch in carcinogenesis
- (2009) Vanessa Baeriswyl et al. SEMINARS IN CANCER BIOLOGY
- Building and operating an antibody factory: Redox control during B to plasma cell terminal differentiation
- (2008) Silvia Masciarelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started